Ladies and gentlemen,

please find attached a new on-line publication from the UCLA (Reed et al.) on non-HLA antibodies and rejection in organ transplantation.

The message is that AECA (anti-endothelial cellantibodies) are contributing to post transplant complications and that Absorber XM-ONE (test system for the detection of AECA) can help detecting these antibodies.

Abstract: There is a growing body of data supporting a role for non-HLA antibodies in acute and chronic rejection of solid organ transplants. While many of these non-HLA antigens remain poorly defined, the principal antigenic targets are expressed on cells of the allograft including endothelium and epithelium. These non-HLA antigens are classified as either alloantigens, such as the major histocompatibility complex class I chain- related gene A (MICA) or MICB, or tissue-specific autoantigens such as vimentin, cardiac myosin (CM), collagen V (Col V), agrin, and angiotensin II receptor type I (AT1). Herein we provide an overview of the non-MHC antigenic targets that have been implicated in graft rejection and discuss the interplay between alloimmunity and autoreactivity in graft rejection.

Please do not hesitate to contact us for further information.

Thank you for your attention and best regards

Julia Hirtle
Sales and Marketing Manager Distribution